MarketCap
Facebook
X
Telegram
Tenax Therapeutics Total Inventories | TENX
Annual Total Inventories Tenax Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 1967 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 99.2 K | 83.4 K | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 99.2 K | 83.4 K | 91.3 K |
Quarterly Total Inventories Tenax Therapeutics
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 97.4 K | - | - | - | 108 K | 98 K | 98.9 K | 99.2 K | 117 K | 109 K | 114 K | 83.4 K | - | 95.7 K | 205 K | 257 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 257 K | 83.4 K | 124 K |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AbbVie
ABBV
|
4.95 B | $ 263.04 | 0.49 % | $ 465 B |  USA |
 |
AbCellera Biologics
ABCL
|
6.34 M | $ 11.41 | 2.15 % | $ 3.41 B |  Canada |
 |
Aclaris Therapeutics
ACRS
|
791 K | $ 5.53 | 6.02 % | $ 678 M | USA |
 |
ADC Therapeutics SA
ADCT
|
4.18 M | $ 1.09 | 3.74 % | $ 139 M |  Schweiz |
 |
Clovis Oncology
CLVS
|
13.7 M | - | -7.23 % | $ 13 M | USA |
 |
ADMA Biologics
ADMA
|
206 M | $ 8.61 | 0.16 % | $ 2.05 B | USA |
 |
Eiger BioPharmaceuticals
EIGR
|
1.56 M | - | -9.21 % | $ 2.55 M | USA |
 |
Guardion Health Sciences
GHSI
|
2.68 M | - | -0.31 % | $ 3.64 M | USA |
 |
G1 Therapeutics
GTHX
|
12.4 M | - | - | $ 370 M | USA |
 |
Intercept Pharmaceuticals
ICPT
|
6.46 M | - | - | $ 643 M | USA |
 |
Intra-Cellular Therapies
ITCI
|
26.3 M | - | - | $ 13.6 B | USA |
 |
La Jolla Pharmaceutical Company
LJPC
|
6.28 M | - | - | $ 154 M | USA |
 |
Merrimack Pharmaceuticals
MACK
|
14.6 M | - | - | $ 216 M | USA |
 |
Mirati Therapeutics
MRTX
|
3.02 M | - | - | $ 3.3 B | USA |
 |
9 Meters Biopharma
NMTR
|
101 K | - | -42.97 % | $ 1.05 M | USA |
 |
Oncternal Therapeutics
ONCT
|
161 K | - | -24.12 % | $ 1.56 M | USA |
 |
Orchard Therapeutics plc
ORTX
|
3.4 M | - | 1.02 % | $ 90.8 M |  Britain |